These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32534450)

  • 21. Urinary levels of tumor-associated trypsin inhibitor (TATI) in the detection of transitional cell carcinoma of the urinary bladder.
    Shariat SF; Herman MP; Casella R; Lotan Y; Karam JA; Stenman UH
    Eur Urol; 2005 Sep; 48(3):424-31. PubMed ID: 15963628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of N-Myc Downstream-Regulated Gene 2 in Bladder Cancer and Its Potential Utility as a Urinary Diagnostic Biomarker.
    Zhang M; Ren B; Li Z; Niu W; Wang Y
    Med Sci Monit; 2017 Sep; 23():4644-4649. PubMed ID: 28953854
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Panel of Urinary Diagnostic Markers for Non-Invasive Detection of Primary and Recurrent Urothelial Urinary Bladder Carcinoma.
    Soukup V; Kalousová M; Capoun O; Sobotka R; Breyl Z; Pešl M; Zima T; Hanuš T
    Urol Int; 2015; 95(1):56-64. PubMed ID: 25662337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of urinary topoisomerase-IIA cell-free DNA for diagnosis of bladder cancer.
    Kim YH; Yan C; Lee IS; Piao XM; Byun YJ; Jeong P; Kim WT; Yun SJ; Kim WJ
    Investig Clin Urol; 2016 Mar; 57(2):106-12. PubMed ID: 26981592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary tissue polypeptide-specific antigen for the diagnosis of bladder cancer.
    Sánchez-Carbayo M; Urrutia M; Silva JM; Romaní R; García J; Alférez F; González deBuitrago JM; Navajo JA
    Urology; 2000 Apr; 55(4):526-32. PubMed ID: 10736496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer.
    Jeong S; Park Y; Cho Y; Kim YR; Kim HS
    Clin Chim Acta; 2012 Dec; 414():93-100. PubMed ID: 22944145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of bladder cancer with aberrantly fucosylated ITGA3.
    Islam MK; Syed P; Dhondt B; Gidwani K; Pettersson K; Lamminmäki U; Leivo J
    Anal Biochem; 2021 Sep; 628():114283. PubMed ID: 34102169
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder.
    Stampfer DS; Carpinito GA; Rodriguez-Villanueva J; Willsey LW; Dinney CP; Grossman HB; Fritsche HA; McDougal WS
    J Urol; 1998 Feb; 159(2):394-8. PubMed ID: 9649246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis.
    Eissa S; Matboli M; Essawy NO; Kotb YM
    Tumour Biol; 2015 Dec; 36(12):9545-52. PubMed ID: 26138586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urinary cell-free microRNA biomarker could discriminate bladder cancer from benign hematuria.
    Piao XM; Jeong P; Kim YH; Byun YJ; Xu Y; Kang HW; Ha YS; Kim WT; Lee JY; Woo SH; Kwon TG; Kim IY; Moon SK; Choi YH; Cha EJ; Yun SJ; Kim WJ
    Int J Cancer; 2019 Jan; 144(2):380-388. PubMed ID: 30183088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-free lncRNA expression signatures in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Du L; Duan W; Jiang X; Zhao L; Li J; Wang R; Yan S; Xie Y; Yan K; Wang Q; Wang L; Yang Y; Wang C
    J Cell Mol Med; 2018 May; 22(5):2838-2845. PubMed ID: 29516641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of urine NMP22 point-of-care test for the screening of bladder cancer].
    Ihm CH; Kim JM; Sohn YH
    Korean J Lab Med; 2007 Apr; 27(2):106-10. PubMed ID: 18094560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of nuclear matrix protein 22 as a tumour marker in the detection of transitional cell carcinoma of the bladder.
    Sánchez-Carbayo M; Herrero E; Megías J; Mira A; Soria F
    BJU Int; 1999 Oct; 84(6):706-13. PubMed ID: 10510120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microchips for detection of exfoliated tumor cells in urine for identification of bladder cancer.
    Liang L; Wang Y; Lu S; Kong M; Lin Y; Cuzzucoli F; Wang P; Wang S
    Anal Chim Acta; 2018 Dec; 1044():93-101. PubMed ID: 30442409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression test for the non-invasive diagnosis of bladder cancer: A prospective, blinded, international and multicenter validation study.
    Ribal MJ; Mengual L; Lozano JJ; Ingelmo-Torres M; Palou J; Rodríguez-Faba O; Witjes JA; Van der Heijden AG; Medina R; Conde JM; Marberger M; Schmidbauer J; Fernández PL; Alcaraz A
    Eur J Cancer; 2016 Feb; 54():131-138. PubMed ID: 26761785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
    Critelli R; Fasanelli F; Oderda M; Polidoro S; Assumma MB; Viberti C; Preto M; Gontero P; Cucchiarale G; Lurkin I; Zwarthoff EC; Vineis P; Sacerdote C; Matullo G; Naccarati A
    Oncotarget; 2016 Oct; 7(41):67435-67448. PubMed ID: 27611947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical comparison of noninvasive urine tests for ruling out recurrent urothelial carcinoma.
    Lotan Y; OʼSullivan P; Raman JD; Shariat SF; Kavalieris L; Frampton C; Guilford P; Luxmanan C; Suttie J; Crist H; Scherr D; Asroff S; Goldfischer E; Thill J; Darling D
    Urol Oncol; 2017 Aug; 35(8):531.e15-531.e22. PubMed ID: 28366272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NMP22 is a sensitive, cost-effective test in patients at risk for bladder cancer.
    Zippe C; Pandrangi L; Agarwal A
    J Urol; 1999 Jan; 161(1):62-5. PubMed ID: 10037369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble Fas--a promising novel urinary marker for the detection of recurrent superficial bladder cancer.
    Svatek RS; Herman MP; Lotan Y; Casella R; Hsieh JT; Sagalowsky AI; Shariat SF
    Cancer; 2006 Apr; 106(8):1701-7. PubMed ID: 16541433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of the NMP22 test and comparison with voided urine cytology in the detection of bladder cancer.
    Lee KH
    Yonsei Med J; 2001 Feb; 42(1):14-8. PubMed ID: 11293494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.